Physician profile
Maritza Samuel
NPI 1871692384
$524.03
in general payments reported to CMS, 2019-2025
6 companies · $44.81 in 2025
The $44.81 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $335 · 2020: $42.48 · 2021: $45.02 · 2023: $35.27 · 2024: $21.95 · 2025: $44.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $102.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $194.54 | 2019-2025 | |
| Glaxosmithkline, LLC. | $112.09 | 2019 | |
| Pfizer INC. | $96.27 | 2019 | |
| Janssen Products, LP | $96.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.75 | 2019 | |
| Cranial Technologies, INC | $12.38 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maritza Samuel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.